Activation Markers on B and T Cells and Immune Checkpoints in Autoimmune Rheumatic Diseases
Article in International Journal of Molecular Sciences (August 2022)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study
Article in Frontiers in Pharmacology (June 2022)
Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy
Article in Cancer Immunology, Immunotherapy (November 2021)